• CONTACT
  • NEWS & MEDIA
  • UPCOMING EVENTS
  • Canady Helios Cold Plasma
  • Canady Hybrid Plasma
    • Canady Hybrid Plasma Technology
    • Canady Plasma XL 1000 Smart Electrosurgical Generator
    • Canady Hybrid Plasma™ Scalpel
    • Canady Plasma Probes
  • Our Treatment
  • Science of Plasma
  • About Us
    • Message From CEO
    • Mission/Vision
    • Management Team
    • Company Milestones
  • Our Patients
    • PATIENT FOCUS
    • Clinical Trial

Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy

by PVA_Admin | Dec 21, 2020 | 2020 Press Release, Press Release

Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy Clinical trial tests ionized beam of room-temperature helium gas that helps body program cancer cells for death Rush University Medical Center cancer surgeons have performed the nation’s first...

Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer

by PVA_Admin | Sep 16, 2020 | 2020 Press Release, Press Release

Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS) in collaboration with US...

JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19

by PVA_Admin | Apr 29, 2020 | 2020 Press Release, Press Release

JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19 TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent...

Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer

by PVA_Admin | Jan 29, 2020 | 2020 Press Release, Press Release

Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–A surgical team at The Chaim Sheba Medical Center in Tel HaShomer, Israel, with...

Recent Posts

  • US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
  • USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
  • Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
  • The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer
  • USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™

Recent Comments

No comments to show.

CANADY HELIOS COLD PLASMA ›

CANADY HYBRID PLASMA ›

OUR TREATMENT ›

SCIENCE OF PLASMA ›

ABOUT US ›

OUR PATIENTS ›

NEWS & MEDIA ›

CONTACT USMI ›

Copyright © 2025 US Medical Innovations